# Immuneering Corp: Form 8-K, filed Jan 18, 2022

- Company: [Immuneering Corp](/companies/imrx.md) (CIK 1790340)
- Form: 8-K
- Filed: 2022-01-18
- Accepted by EDGAR: Jan 18, 2022, 06:56 ET
- Period: 2022-01-14
- Accession: 0001104659-22-004651
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1790340/000110465922004651/tm223100d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1790340/000110465922004651/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1790340/000110465922004651/tm223100d1_8k.htm

Filed Jan 18, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-004651. Last ingested by Listed: Nov 10, 2026, 03:06 ET. No prices; not investment advice.
